{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:14:35Z","timestamp":1769008475050,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The U.S. Ending the HIV epidemic (EHE) plan aims to reduce annual HIV incidence by 90% by 2030, by first focusing interventions on 57 regions (EHE jurisdictions) that contributed to more than 50% of annual HIV diagnoses. Mathematical models that project HIV incidence evaluate the impact of interventions and inform intervention decisions. However, current models are either national level, which do not consider jurisdictional heterogeneity, or independent jurisdiction-specific, which do not consider cross jurisdictional interactions. Data suggests that a significant proportion of persons have sexual partnerships outside their own jurisdiction. However, the sensitivity of these jurisdictional interactions on model outcomes and intervention decisions hasn\u2019t been studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed an ordinary differential equations based compartmental model to generate national-level projections of HIV in the U.S., through dynamic simulations of 96 epidemiological sub-models representing 54 EHE and 42 non-EHE jurisdictions. A Bernoulli equation modeled HIV-transmissions using a mixing matrix to simulate sexual partnerships within and outside jurisdictions. To evaluate sensitivity of jurisdictional interactions on model outputs, we analyzed 16 scenarios, combinations of a) proportion of sexual partnerships mixing outside jurisdiction: no-mixing, low-level-mixing-within-state, high-level-mixing-within-state, or high-level-mixing-within-and-outside-state; b) jurisdictional heterogeneity in care and demographics: homogenous or heterogeneous; and c) intervention assumptions for 2019\u20132030: baseline or EHE-plan (diagnose, treat, and prevent).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Change in incidence in mixing compared to no-mixing scenarios varied by EHE and non-EHE jurisdictions and aggregation-level. When assuming jurisdictional heterogeneity and baseline-intervention, the change in aggregated incidence ranged from \u2212\u20092 to 0% for EHE and 5 to 21% for non-EHE, but within each jurisdiction it ranged from \u2212\u200931 to 46% for EHE and\u2009\u2212\u200918 to 109% for non-EHE. Thus, incidence estimates were sensitive to jurisdictional mixing more at the jurisdictional level. As a result, jurisdiction-specific HIV-testing intervals inferred from the model to achieve the EHE-plan were also sensitive, e.g., when no-mixing scenarios suggested testing every 1\u2009year (or 3\u2009years), the three mixing-levels suggested testing every 0.8 to 1.2\u2009years, 0.6 to 1.5\u2009years, and 0.6 to 1.5\u2009years, respectively (or 2.6 to 3.5\u2009years, 2 to 4.8\u2009years, and 2.2 to 4.1\u2009years, respectively). Similar patterns were observed when assuming jurisdictional homogeneity, however, change in incidence in mixing compared to no-mixing scenarios were high even in aggregated incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Accounting jurisdictional mixing and heterogeneity could improve model-based analyses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12874-022-01756-w","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:18:52Z","timestamp":1669511932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan"],"prefix":"10.1186","volume":"22","author":[{"given":"Hanisha","family":"Tatapudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitra","family":"Gopalappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"1756_CR1","unstructured":"Clinical Info HIV.gov, \u201cU.S. Statistics,\u201d Jun. 02, 2021. https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/statistics (Accessed 12 Aug 2021)."},{"key":"1756_CR2","unstructured":"National Institutes of Health (NIH), \u201cHIV Treatment.\u201d https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/hiv-treatment-basics (Accessed 12 Aug 2021)."},{"key":"1756_CR3","unstructured":"Centers for Disease Control and Prevention (CDC), \u201cPrEP Effectiveness,\u201d May 13, 2021. https:\/\/www.cdc.gov\/hiv\/basics\/prep\/prep-effectiveness.html (Accessed 20 Aug 2021)."},{"key":"1756_CR4","unstructured":"America\u2019s HIV Epidemic Analysis Dashboard (AHEAD), \u201cWhat is AHEAD?\u201d https:\/\/ahead.hiv.gov\/about (Accessed 12 Aug 2021)."},{"key":"1756_CR5","unstructured":"HIV.gov, \u201cWhat Is Ending the HIV Epidemic in the U.S.?,\u201d Jun. 02, 2021. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview (Accessed 12 Aug 2021)."},{"key":"1756_CR6","unstructured":"Centers for Disease Control and Prevention (CDC), \u201cEnding the HIV Epidemic in the U.S. (EHE),\u201d Sep. 07, 2021. https:\/\/www.cdc.gov\/endhiv\/jurisdictions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fendhiv%2Fpriorities.html (Accessed 14 Dec 2021)."},{"key":"1756_CR7","unstructured":"Clinical Info HIV.gov, \u201cPrior National HIV\/AIDS Strategies (2010\u20132021),\u201d Dec. 01, 2021. https:\/\/www.hiv.gov\/federal-response\/national-hiv-aids-strategy\/national-hiv-aids-strategies-2010-2021 (Accessed 17 Dec 2021)."},{"issue":"5","key":"1756_CR8","doi-asserted-by":"publisher","first-page":"e0217559","DOI":"10.1371\/journal.pone.0217559","volume":"14","author":"E Krebs","year":"2019","unstructured":"Krebs E, et al. Developing a dynamic HIV transmission model for 6 U.S. cities: an evidence synthesis. PLoS One. 2019;14(5):e0217559. https:\/\/doi.org\/10.1371\/journal.pone.0217559.","journal-title":"PLoS One"},{"issue":"12","key":"1756_CR9","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1093\/cid\/ciz1015","volume":"69","author":"B Nosyk","year":"2019","unstructured":"Nosyk B, et al. Ending the epidemic in America will not happen if the status quo continues: modeled projections for human immunodeficiency virus incidence in 6 US cities. Clin Infect Dis. 2019;69(12):2195\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz1015.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1756_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0272989X19889356","volume":"40","author":"X Zang","year":"2020","unstructured":"Zang X, et al. Development and calibration of a dynamic HIV transmission model for 6 US cities. Med Decis Mak. 2020;40(1):3\u201316. https:\/\/doi.org\/10.1177\/0272989X19889356.","journal-title":"Med Decis Mak"},{"issue":"7","key":"1756_CR11","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1016\/S2352-3018(20)30033-3","volume":"7","author":"B Nosyk","year":"2020","unstructured":"Nosyk B, et al. Ending the HIV epidemic in the USA: an economic modelling study in six cities. The Lancet HIV. 2020;7(7):e491\u2013503. https:\/\/doi.org\/10.1016\/S2352-3018(20)30033-3.","journal-title":"The Lancet HIV"},{"issue":"Supplement_5","key":"1756_CR12","doi-asserted-by":"publisher","first-page":"S301","DOI":"10.1093\/infdis\/jiaa130","volume":"222","author":"E Krebs","year":"2020","unstructured":"Krebs E, et al. Ending the HIV epidemic among persons who inject drugs: a cost-effectiveness analysis in six US cities. J Infect Dis. 2020;222(Supplement_5):S301\u201311. https:\/\/doi.org\/10.1093\/infdis\/jiaa130.","journal-title":"J Infect Dis"},{"issue":"15","key":"1756_CR13","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1097\/QAD.0000000000002668","volume":"34","author":"X Zang","year":"2020","unstructured":"Zang X, et al. Can the \u2018ending the HIV epidemic\u2019 initiative transition the USA towards HIV\/AIDS epidemic control? AIDS. 2020;34(15):2325\u20138. https:\/\/doi.org\/10.1097\/QAD.0000000000002668.","journal-title":"AIDS"},{"issue":"11","key":"1756_CR14","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/cid\/ciaa566","volume":"71","author":"B Nosyk","year":"2020","unstructured":"Nosyk B, et al. \u2018Ending the epidemic\u2019 will not happen without addressing racial\/ethnic disparities in the United States human immunodeficiency virus epidemic. Clin Infect Dis. 2020;71(11):2968\u201371. https:\/\/doi.org\/10.1093\/cid\/ciaa566.","journal-title":"Clin Infect Dis"},{"key":"1756_CR15","doi-asserted-by":"publisher","unstructured":"Quan AML, et al. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The Lancet HIV. 2021:S2352301821001478. https:\/\/doi.org\/10.1016\/S2352-3018(21)00147-8.","DOI":"10.1016\/S2352-3018(21)00147-8"},{"issue":"11","key":"1756_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.7326\/M21-1501","volume":"174","author":"AT Fojo","year":"2021","unstructured":"Fojo AT, Schnure M, Kasaie P, Dowdy DW, Shah M. What will it take to end HIV in the United States?: a comprehensive, local-level modeling study. Ann Intern Med. 2021;174(11):1542\u201353. https:\/\/doi.org\/10.7326\/M21-1501.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1756_CR17","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.3934\/mbe.2021380","volume":"18","author":"SN Khatami","year":"2021","unstructured":"Khatami SN, Gopalappa C, Mechanical and Industrial Engineering Department, University of Massachusetts Amherst, Amherst, MA 01003, USA. A reinforcement learning model to inform optimal decision paths for HIV elimination. MBE. 2021;18(6):7666\u201384. https:\/\/doi.org\/10.3934\/mbe.2021380.","journal-title":"MBE"},{"issue":"4","key":"1756_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0000000000001707","volume":"78","author":"N Khurana","year":"2018","unstructured":"Khurana N, et al. Impact of improved HIV care and treatment on PrEP effectiveness in the United States, 2016\u20132020. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2018;78(4):399\u2013405. https:\/\/doi.org\/10.1097\/QAI.0000000000001707.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"1756_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/OLQ.0b013e3181f7d7f4","volume":"38","author":"RM Gindi","year":"2011","unstructured":"Gindi RM, Sifakis F, Sherman SG, Towe VL, Flynn C, Zenilman JM. The geography of heterosexual partnerships in Baltimore City adults. Sex Transm Dis. 2011;38(4):260\u20136. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181f7d7f4.","journal-title":"Sex Transm Dis"},{"issue":"17","key":"1756_CR20","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/QAD.0b013e32834bfde9","volume":"25","author":"AM Oster","year":"2011","unstructured":"Oster AM, et al. Demographic but not geographic insularity in HIV transmission among young black MSM. AIDS. 2011;25(17):2157\u201365. https:\/\/doi.org\/10.1097\/QAD.0b013e32834bfde9.","journal-title":"AIDS"},{"issue":"1","key":"1756_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/QAI.0000000000000404","volume":"68","author":"RJ Lubelchek","year":"2015","unstructured":"Lubelchek RJ, Hoehnen SC, Hotton AL, Kincaid SL, Barker DE, French AL. Transmission clustering among newly diagnosed HIV patients in Chicago, 2008 to 2011: using Phylogenetics to expand knowledge of regional HIV transmission patterns. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2015;68(1):46\u201354. https:\/\/doi.org\/10.1097\/QAI.0000000000000404.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"2","key":"1756_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jinf.2017.05.009","volume":"75","author":"X Li","year":"2017","unstructured":"Li X, et al. Multiple introductions and onward transmission of HIV-1 subtype B strains in Shanghai, China. J Inf Secur. 2017;75(2):160\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2017.05.009.","journal-title":"J Inf Secur"},{"issue":"6","key":"1756_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/OLQ.0000000000000752","volume":"45","author":"D Gesink","year":"2018","unstructured":"Gesink D, et al. Conceptualizing Geosexual archetypes: mapping the sexual travels and egocentric sexual networks of gay and bisexual men in Toronto, Canada. Sexual Trans Dis. 2018;45(6):368\u201373. https:\/\/doi.org\/10.1097\/OLQ.0000000000000752.","journal-title":"Sexual Trans Dis"},{"issue":"3","key":"1756_CR24","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/QAI.0000000000002448","volume":"85","author":"AR Board","year":"2020","unstructured":"Board AR, et al. Geographic distribution of HIV transmission networks in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020;85(3):e32\u201340. https:\/\/doi.org\/10.1097\/QAI.0000000000002448.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"1756_CR25","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.2196\/publichealth.5365","volume":"2","author":"JA Grey","year":"2016","unstructured":"Grey JA, et al. Estimating the population sizes of men who have sex with men in US states and counties using data from the American community survey. JMIR Public Health Surveill. 2016;2(1):e14. https:\/\/doi.org\/10.2196\/publichealth.5365.","journal-title":"JMIR Public Health Surveill"},{"key":"1756_CR26","unstructured":"\u201cNCHHSTP AtlasPlus.\u201d https:\/\/www.cdc.gov\/nchhstp\/atlas\/index.htm (Accessed 04 Nov 2021)."},{"key":"1756_CR27","unstructured":"\u201cPrEP for HIV Prevention in the U.S.\u201d https:\/\/www.cdc.gov\/nchhstp\/newsroom\/fact-sheets\/hiv\/PrEP-for-hiv-prevention-in-the-US-factsheet.html (Accessed 30 Jun 2022)."},{"key":"1756_CR28","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.15585\/mmwr.mm7047a3","volume":"70","author":"AR Baugher","year":"2021","unstructured":"Baugher AR, et al. Racial, ethnic, and gender disparities in awareness of Preexposure prophylaxis among HIV-negative heterosexually active adults at increased risk for HIV infection - 23 urban areas, United States, 2019. MMWR Morb Mortal Wkly Rep. 2021;70:1635\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7047a3 Accessed 30 Jun 2022.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1756_CR29","volume-title":"Annual County resident population estimates by age, sex, race, and Hispanic origin: April 1, 2010 to July 1, 2019","author":"United States Census Bureau","year":"2020","unstructured":"United States Census Bureau. Annual County resident population estimates by age, sex, race, and Hispanic origin: April 1, 2010 to July 1, 2019; 2020. https:\/\/www2.census.gov\/programs-surveys\/popest\/datasets\/2010-2019\/counties\/asrh\/cc-est2019-alldata.csv (Accessed 4 Nov 2021)"},{"key":"1756_CR30","unstructured":"America\u2019s HIV Epidemic Analysis Dashboard (AHEAD), \u201cFAQs,\u201d EHE Goals: What are the 2025 goals and 2030 goals for each of the indicators? https:\/\/ahead.hiv.gov\/faqs (Accessed 20 Aug 2021)."},{"key":"1756_CR31","unstructured":"Clinical Info HIV.gov, \u201cRecommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States,\u201d Dec. 29, 2020. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/perinatal\/prep (Accessed 8 Nov\u00a02021)."}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-022-01756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-022-01756-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-022-01756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:23:13Z","timestamp":1669512193000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-022-01756-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1186\/s12874-022-01756-w","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"31 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Relevant guidelines and regulations were practiced where applicable in the gathering and handling of human data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}